Eli Lilly And reported $3.83B in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
ALKERMES ALKS:US USD 166.3M 10.69M
Amgen AMGN:US USD 4.76B 203M
Baxter International BAX:US USD 2.68B 12M
Biogen BIIB:US USD 1.38B 80.8M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Catalent CTLT:US USD 753M 29M
Coherus Biosciences CHRS:US USD 27.72M 4.02M
Eli Lilly And LLY:US USD 3.83B 68.3M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Horizon Pharma HZNP:US USD 190.26M 13.42M
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Lannett LCI:US USD 94.12M 1.04M
Medtronic MDT:US USD 5.06B 246M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Novartis NOVN:VX USD 6.78B 101M
Perrigo Ordinary Shares PRGO:US USD 1.09B 5.6M
Phibro Animal Health PAHC:US USD 280.84M 21.68M
Prestige Brands PBH:US USD 140.5M 6.74M
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Revance Therapeutics RVNC:US USD 17.18M 3.58M
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M
United Therapeutics UTHR:US USD 91M 1.1M
Zoetis ZTS:US USD 2.3B 98M